The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review
- PMID: 37555985
- DOI: 10.1007/s00345-023-04521-w
The diagnostic accuracy of micro-ultrasound for prostate cancer diagnosis: a review
Abstract
Purpose: Micro-UltraSound (microUS) is a new imaging modality capable of identifying and targeting suspicious areas, which might further increase the diagnostic yield of prostate biopsy (PBx). Aim of this review is to provide insights into the usefulness of microUS for the sub-stratification of prostate cancer (PCa), clinically significant PCa (i.e., any Gleason score ≥ 7 PCa; csPCa) along with non-organ-confined disease in patients undergoing PBx.
Methods: A PubMed literature search was performed using keywords: prostate cancer diagnosis, prostate cancer diagnosis surveillance, systematic biopsy, target biopsy, micro-ultrasound, and prostate risk identification using micro-ultrasound.
Results: MicroUS could significantly improve multiparametric magnetic resonance imaging (mpMRI) findings by adding valuable anatomical and pathological information provided by real-time examination. Furthermore, microUS target biopsy could replace systematic biopsy in clinical practice by reducing the detection of clinically insignificant (ciPCa) and increasing that of csPCa. Finally, microUS may be useful in predicting the presence of non-organ confined PCa before radical prostatectomy and it could also be an effective add-on tool for patient monitoring within the active surveillance program.
Conclusion: MicroUS may represent an attractive step forward for the management of csPCa as a complementary or alternative tool to mpMRI. Nevertheless, further longitudinal studies are warranted, and the strength of the evidence is still suboptimal to provide clear recommendations for daily clinical practice.
Keywords: Active surveillance; Micro-ultrasound; Multiparametric magnetic resonance imaging; Prostate cancer; Transrectal ultrasound.
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Optimization of prostate biopsy - Micro-Ultrasound versus MRI (OPTIMUM): A 3-arm randomized controlled trial evaluating the role of 29 MHz micro-ultrasound in guiding prostate biopsy in men with clinical suspicion of prostate cancer.Contemp Clin Trials. 2022 Jan;112:106618. doi: 10.1016/j.cct.2021.106618. Epub 2021 Nov 1. Contemp Clin Trials. 2022. PMID: 34728381 Clinical Trial.
-
Prostate Cancer Diagnosis with Micro-ultrasound: What We Know now and New Horizons.Radiol Clin North Am. 2024 Jan;62(1):189-197. doi: 10.1016/j.rcl.2023.06.014. Epub 2023 Aug 21. Radiol Clin North Am. 2024. PMID: 37973243 Review.
-
Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.Prostate. 2022 Feb;82(3):388-396. doi: 10.1002/pros.24286. Epub 2021 Dec 16. Prostate. 2022. PMID: 34914121 Free PMC article.
-
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer.Prostate. 2023 Jun;83(9):886-895. doi: 10.1002/pros.24532. Epub 2023 Apr 4. Prostate. 2023. PMID: 36960788
-
The Use of Multiparametric Magnetic Resonance Imaging (mpMRI) in the Detection, Evaluation, and Surveillance of Clinically Significant Prostate Cancer (csPCa).Curr Urol Rep. 2019 Sep 2;20(10):60. doi: 10.1007/s11934-019-0926-0. Curr Urol Rep. 2019. PMID: 31478113 Review.
Cited by
-
Personalized High-Resolution Genetic Diagnostics of Prostate Adenocarcinoma Guided by Multiparametric Magnetic Resonance Imaging: Results of a Pilot Study.Int J Mol Sci. 2025 Jun 12;26(12):5648. doi: 10.3390/ijms26125648. Int J Mol Sci. 2025. PMID: 40565112 Free PMC article.
-
ProCUSNet: Prostate Cancer Detection on B-mode Transrectal Ultrasound Using Artificial Intelligence for Targeting During Prostate Biopsies.Eur Urol Oncol. 2025 Apr;8(2):477-485. doi: 10.1016/j.euo.2024.12.012. Epub 2025 Jan 28. Eur Urol Oncol. 2025. PMID: 39880746
-
Navigating Focal Therapy for Prostate Cancer: Contemporary Perspectives and Future Trajectories in the Canadian Context.J Endourol. 2025 Mar;39(S2):S29-S37. doi: 10.1089/end.2024.0619. Epub 2024 Nov 29. J Endourol. 2025. PMID: 39612186 Review.
-
A Propensity Score-matched Comparison of Micro-ultrasound-guided Transrectal and Magnetic Resonance Imaging/Transrectal Ultrasound Fusion-guided Transperineal Prostate Biopsies for Detection of Clinically Significant Prostate Cancer.Eur Urol Open Sci. 2024 Sep 12;69:7-12. doi: 10.1016/j.euros.2024.08.013. eCollection 2024 Nov. Eur Urol Open Sci. 2024. PMID: 39314912 Free PMC article.
-
Evaluating the Effectiveness and Safety of Robotic-Assisted MRI/TRUS Fusion Transperineal Prostate Biopsy Systems: A Narrative Review Based on Current Literature.Eurasian J Med. 2023 Dec;55(1):125-130. doi: 10.5152/eurasianjmed.2023.23370. Eurasian J Med. 2023. PMID: 39128089 Free PMC article.
References
-
- Gandaglia G, Albers P, Abrahamsson P-A et al (2019) Structured population-based prostate-specific antigen screening for prostate cancer: the European Association of Urology position in 2019. Eur Urol 76:142–150. https://doi.org/10.1016/j.eururo.2019.04.033 - DOI - PubMed
-
- Klotz L, Chin J, Black PC et al (2021) Comparison of multiparametric magnetic resonance imaging-targeted biopsy with systematic transrectal ultrasonography biopsy for biopsy-naive men at risk for prostate cancer: a phase 3 randomized clinical trial. JAMA Oncol 7:534. https://doi.org/10.1001/jamaoncol.2020.7589 - DOI - PubMed - PMC
-
- Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med 378:1767–1777. https://doi.org/10.1056/NEJMoa1801993 - DOI - PubMed - PMC
-
- van der Leest M, Cornel E, Israël B et al (2019) Head-to-head comparison of transrectal ultrasound-guided prostate biopsy versus multiparametric prostate resonance imaging with subsequent magnetic resonance-guided biopsy in biopsy-naïve men with elevated prostate-specific antigen: a large prospective multicenter clinical study. Eur Urol 75:570–578. https://doi.org/10.1016/j.eururo.2018.11.023 - DOI - PubMed
-
- Rouvière O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100–109. https://doi.org/10.1016/S1470-2045(18)30569-2 - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical